MI-VAD, Inc. is pleased to announce the appointment of Lyle Joyce MD PhD, of Milwaukee, Wisconsin to our Technical Advisory Board.

“Surgeons have wished for a truly intra-cavitary blood pump for years and the thought of a universal pump that can serve either the right or left side (or both) is a dream come true.  I am excited to have this opportunity to help bring this design to clinical fruition.  It will be a complete game changer for mechanical circulatory support”.

Dr. Joyce earned his Doctorate of Medicine from Baylor College of Medicine in 1973, and received his Ph.D. in 1982 from the University of Minnesota. Dr. Joyce completed his internship and residencies at the University of Minnesota Hospital (General Surgery), Dr. Jesse Edwards Miller Hospital (Cardiovascular Pathology), and the University of Utah (Cardiothoracic Surgery).

Dr. Joyce has been practicing in the field of cardiothoracic surgery for nearly 40 years, focusing on heart transplantation and the surgical treatment of heart failure. He is world-renowned in the field of cardiothoracic surgery having been on the team that implanted the first permanent artificial heart in a man, and was the first surgeon ever to use a total artificial heart in a woman. He has won numerous awards during the course of his distinguished career. He has also published countless peer reviewed articles in the field of heart failure and mechanical circulatory assist.  Dr. Joyce has also served as a Principal Investigator of many LVAD clinical trials.

Since 2017, Dr. Joyce has served as the Section Chief of Adult Cardiac Surgery at the Medical College of Wisconsin. Prior thereto, he served as Professor of Surgery and Director of the Advanced Heart Failure and Assist Device Program at the Mayo Clinic, Rochester, Minnesota.

Together with his son David who is a respected cardiac surgeon in his own right, Dr. Joyce co-authored “Mechanical Circulatory Support: Principles and Applications”, an all-in-one textbook guide to mechanical assist devices for the treatment of heart failure.  Published in 2011, it addresses all of the clinical scenarios encountered by the health care team during the pre-operative, intra-operative, and post-operative periods following device implantation. In addition, it outlines the specific attributes of various technologies utilized by clinicians at the time of publication, giving a practical view of how the LVAD devices work.

MI-VAD, Inc. is a privately owned developmental stage medical device company that is continuing its development of a novel and potentially revolutionary minimally invasive mechanical blood circulatory pump, or ventricular assist device (VAD) that can change the management of end-stage heart failure.  For more information, contact us at info@mivadinc.com